A Maintenance Extension of Phase I Pilot Study of Chimeric Anti-CD4 Antibody M-T412 in Patients With Multiple Sclerosis
NCT00004816
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
25
Enrollment
NIH
Sponsor class
Conditions
Multiple Sclerosis
Interventions
DRUG:
monoclonal antibody M-T412
Sponsor
National Center for Research Resources (NCRR)
Collaborators
[object Object]